HS
HighVista Strategies’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.17M | Buy |
+106,553
| New | +$2.17M | 0.8% | 38 |
|
|
2024
Q4 | – | Sell |
-8,981
| Closed | -$305K | – | 148 |
|
|
2024
Q3 | $305K | Sell |
8,981
-646
| -7% | -$22K | 0.11% | 142 |
|
|
2024
Q2 | $356K | Buy |
+9,627
| New | +$356K | 0.13% | 127 |
|
|
2023
Q4 | – | Sell |
-17,482
| Closed | -$481K | – | 129 |
|
|
2023
Q3 | $481K | Sell |
17,482
-7,260
| -29% | -$200K | 0.22% | 113 |
|
|
2023
Q2 | $839K | Hold |
24,742
| – | – | 0.38% | 61 |
|
|
2023
Q1 | $890K | Hold |
24,742
| – | – | 0.73% | 41 |
|
|
2022
Q4 | $1.1M | Sell |
24,742
-684
| -3% | -$30.5K | 0.65% | 38 |
|
|
2022
Q3 | $715K | Buy |
25,426
+3,014
| +13% | +$84.8K | 0.41% | 69 |
|
|
2022
Q2 | $604K | Sell |
22,412
-3,326
| -13% | -$89.6K | 0.36% | 69 |
|
|
2022
Q1 | $877K | Sell |
25,738
-4,118
| -14% | -$140K | 0.56% | 48 |
|
|
2021
Q4 | $1.15M | Buy |
29,856
+1,390
| +5% | +$53.7K | 0.92% | 34 |
|
|
2021
Q3 | $1.54M | Sell |
28,466
-5,427
| -16% | -$293K | 1.02% | 18 |
|
|
2021
Q2 | $1.13M | Buy |
33,893
+953
| +3% | +$31.9K | 0.8% | 18 |
|
|
2021
Q1 | $678K | Sell |
32,940
-16,915
| -34% | -$348K | 0.5% | 44 |
|
|
2020
Q4 | $873K | Buy |
49,855
+5,026
| +11% | +$88K | 0.56% | 38 |
|
|
2020
Q3 | $665K | Buy |
+44,829
| New | +$665K | 0.48% | 23 |
|